The invasion-associated locus A and B genes (ialAB) ofBartonella bacilliformis were previously shown to confer an erythrocyte-invasive phenotype upon Escherichia coli, indirectly implicating their role in virulence. We report the first direct demonstration of a role for ialB as a virulence factor in B. bacilliformis. The presence of a secretory signal sequence and amino acid sequence similarity to two known outer membrane proteins involved in virulence suggested that IalB was an outer membrane protein. To develop an antiserum for protein localization, the ialB gene was cloned in frame into an expression vector with a six-histidine tag and under control of thelacZ promoter. The IalB fusion protein was purified by nickel affinity chromatography and used to raise polyclonal antibodies. IalB was initially localized to the bacterial membrane fraction. To further localize IalB, B. bacilliformis inner and outer membranes were fractionated by sucrose density gradient centrifugation and identified by appearance, buoyant density (ρ), and cytochromeb content. Inner and outer membrane proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and IalB was positively identified by Western blot. Contrary to expectations, IalB was localized to the inner membrane of the pathogen. To directly demonstrate a role for IalB in erythrocyte parasitism, the B. bacilliformis ialB gene was disrupted by insertional mutagenesis. The resulting ialB mutant strain was complemented in trans with a replicative plasmid encoding the full-length ialB gene. PCR and high-stringency DNA hybridization confirmed mutagenesis and transcomplementation events. Abrogation and restoration of ialB expression was verified by SDS-PAGE and immunoblotting. In vitro virulence assays showed that mutagenesis of ialB decreased bacterial association and invasion of human erythrocytes by 47 to 53% relative to controls. Transcomplementation of ialB restored erythrocyte association and invasion rates to levels observed in the parental strain. These data provide direct evidence for IalB's role in erythrocyte parasitism and represent the first demonstration of molecular Koch's postulates for a Bartonella species.
Bartonella bacilliformisis the only bacterium known to invade human erythrocytes. The pathogen is the causative agent of the human disease, Oroya fever, a biphasic illness whose primary-phase symptoms include a severe hemolytic anemia, where up to 100% of the circulating erythrocytes can be parasitized and 80% lysed (1, 15, 31). If untreated, this phase of the disease has a 40% fatality rate (44). Treatment with penicillin, tetracycline, or aminoglycosides is effective (43), but diagnosis can be difficult due to the slow growth and fastidious nature of the bacterium. The secondary phase of Oroya fever occurs 4 to 8 weeks following the primary hemolytic phase and is characterized by hemangiomas, nicknamed verruga peruana, on the patient's head, neck, and extremities. During the secondary phase, bacterial colonization and invasion shifts from erythrocytes to vascular endothelial cells (13, 14, 21) and results in neovascularization (13). This phase of the disease is rarely fatal but can last up to several months (43) and may cause permanent disfigurement. B. bacilliformis is transmitted by the phlebotamine sandfly, Lutzomyia verrucarum. Historically, Oroya fever has been limited to the mountainous regions of South America, presumably due to geographical restriction of its vector (19). However, recent reports of Oroya fever in coastal areas of South America suggest that the range of this pathogen is expanding (1).
Although other bacteria are known to parasitize mammalian erythrocytes (e.g., Anaplasma and Haemobartonella species),B. bacilliformis is unsurpassed among bacteria in its efficiency as an erythrocyte parasite. B. bacilliformis is able to invade nearly all circulating erythrocytes during the acute phase of infection. Erythrocytes lack the actin cytoskeleton necessary for bacterial uptake by induced endocytosis, although endocytosis can be induced under experimental conditions (35, 40). Treatment of erythrocytes with glycolysis and proton-motive-force inhibitors has no effect on Bartonella adhesion, suggesting that these host cells play a passive role in invasion (42). In contrast, B. bacilliformis plays an active role during erythrocyte invasion requiring both respiration and proton motive force (42). Taken together, these data indicate that B. bacilliformis is the only active participant in erythrocyte adherence and invasion. In contrast,B. bacilliformis entry into endothelial and epithelial cells differs significantly from its invasion of erythrocytes. Bacterium-induced rearrangement of the endothelial and epithelial cell cytoskeleton during endocytosis enhances bacterial uptake, while cytochalasin D treatment, inhibiting actin filament formation, reduces internalization by ∼30% (21).
The B. bacilliformis invasion-associated locus A and B genes (ialAB) were indirectly shown to be involved in erythrocyte invasion by conferring an erythrocyte-invasive phenotype upon minimally invasive Escherichia coli strains (27). IalA has since been characterized as a (di)nucleoside polyphosphate hydrolase thought to be involved in reducing levels of stress-induced dinucleotides during invasion, thus aiding bacterial survival (9, 11). IalB was shown to contain a putative 22-amino-acid secretory signal sequence and to have approximately 60% amino acid similarity to the virulence determinants Ail of Yersinia enterocolitica and Rck of Salmonella enterica serovar Typhimurium. The presence of a potential secretory sequence and similarity of IalB to two outer membrane virulence determinants led to our hypothesis that IalB is exported to the bacterial surface, where it functions as an invasion factor. This study was undertaken to localize the IalB protein and directly determine its role in human...